Cefepime-Taniborbactam in Complicated Urinary Tract Infection

N Engl J Med. 2024 May 30;390(20):1938. doi: 10.1056/NEJMc2403590.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Anti-Bacterial Agents* / adverse effects
  • Anti-Bacterial Agents* / therapeutic use
  • Cefepime* / therapeutic use
  • Cephalosporins / adverse effects
  • Cephalosporins / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Male
  • Meropenem / adverse effects
  • Meropenem / therapeutic use
  • Microbial Sensitivity Tests
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / microbiology

Substances

  • Anti-Bacterial Agents
  • Cefepime
  • Cephalosporins
  • taniborbactam
  • Meropenem